ANNUAL REPORT 2012 - TiGenix
ANNUAL REPORT 2012 - TiGenix
ANNUAL REPORT 2012 - TiGenix
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
9.2. VOTING RIGHTS<br />
9.3. SHAREHOLDERS’ AGREEMENTS<br />
As further described under section 5.5.1, each<br />
shareholder is entitled to one vote per share.<br />
In an agreement entered into on May 3, 2011,<br />
simultaneously with the completion of the<br />
contribution of the <strong>TiGenix</strong> SAU (previously :<br />
Cellerix SA) shares to the Company, between<br />
<strong>TiGenix</strong> SAU and CX EBIP Agreement, SLU,<br />
CX EBIP Agreement, SLU has unilaterally<br />
undertaken to abstain from : (i) exercising its<br />
voting rights on any shares in the Company<br />
owned by CX EBIP Agreement, SLU and (ii)<br />
attending any shareholders’ meetings of the<br />
Company until the Equity Based Incentive<br />
Plans of <strong>TiGenix</strong> SAU, described in section<br />
7.7.4, have expired.<br />
The Company has no knowledge of any<br />
outstanding agreements between its<br />
shareholders.<br />
9.4. RELATIONS WITH<br />
MAJOR SHAREHOLDERS<br />
<strong>TiGenix</strong> SAU has an agreement with CX EBIP<br />
Agreement, SLU, a wholly-owned subsidiary<br />
of Genetrix Life Sciences A.B., in relations<br />
to the EBIPs. This is set out in more detail in<br />
section 7.7.4.1 (“Summary of the Equity Based<br />
Incentive Plans”).<br />
104 <strong>TiGenix</strong> I annual report <strong>2012</strong>